Search

John J Mason

Examiner (ID: 6497)

Most Active Art Unit
2198
Art Unit(s)
2198
Total Applications
1
Issued Applications
1
Pending Applications
0
Abandoned Applications
0

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7677719 [patent_doc_number] => 20040152107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Gene signature of electroshock therapy and methods of use' [patent_app_type] => new [patent_app_number] => 10/664705 [patent_app_country] => US [patent_app_date] => 2003-09-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31657 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152107.pdf [firstpage_image] =>[orig_patent_app_number] => 10664705 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/664705
Gene signature of electroshock therapy and methods of use Sep 17, 2003 Abandoned
Array ( [id] => 894540 [patent_doc_number] => 07341832 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-03-11 [patent_title] => 'Genes involved in neuropsychiatric disorders' [patent_app_type] => utility [patent_app_number] => 10/649400 [patent_app_country] => US [patent_app_date] => 2003-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 8 [patent_no_of_words] => 27489 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 141 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/341/07341832.pdf [firstpage_image] =>[orig_patent_app_number] => 10649400 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/649400
Genes involved in neuropsychiatric disorders Aug 25, 2003 Issued
Array ( [id] => 7220742 [patent_doc_number] => 20040072275 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-15 [patent_title] => 'Interaction of NMDA receptor with protein tyrosine phosphatase' [patent_app_type] => new [patent_app_number] => 10/633109 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12656 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0072/20040072275.pdf [firstpage_image] =>[orig_patent_app_number] => 10633109 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/633109
Interaction of NMDA receptor with protein tyrosine phosphatase Jul 31, 2003 Abandoned
Array ( [id] => 7672742 [patent_doc_number] => 20040181037 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Phosphatidyl serine receptors and uses thereof' [patent_app_type] => new [patent_app_number] => 10/625492 [patent_app_country] => US [patent_app_date] => 2003-07-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36660 [patent_no_of_claims] => 87 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0181/20040181037.pdf [firstpage_image] =>[orig_patent_app_number] => 10625492 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/625492
Phosphatidyl serine receptors and uses thereof Jul 21, 2003 Abandoned
Array ( [id] => 7395058 [patent_doc_number] => 20040018151 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods' [patent_app_type] => new [patent_app_number] => 10/624199 [patent_app_country] => US [patent_app_date] => 2003-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3553 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018151.pdf [firstpage_image] =>[orig_patent_app_number] => 10624199 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/624199
Use of anandamide/cannabinoid receptor/acceptor agonists in als screening and treatment methods Jul 20, 2003 Abandoned
Array ( [id] => 7364306 [patent_doc_number] => 20040091945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-13 [patent_title] => 'Peptides and methods of screening immunogenic peptide vaccines against Alzheimer\'s Disease' [patent_app_type] => new [patent_app_number] => 10/619454 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14802 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0091/20040091945.pdf [firstpage_image] =>[orig_patent_app_number] => 10619454 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/619454
Peptides and methods of screening immunogenic peptide vaccines against Alzheimer's Disease Jul 15, 2003 Abandoned
Array ( [id] => 7230190 [patent_doc_number] => 20040156841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Human amine transporter' [patent_app_type] => new [patent_app_number] => 10/619485 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11778 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156841.pdf [firstpage_image] =>[orig_patent_app_number] => 10619485 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/619485
Human amine transporter Jul 15, 2003 Abandoned
Array ( [id] => 7364957 [patent_doc_number] => 20040005661 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-08 [patent_title] => 'Potential growth factors from the human tumour cell line ht 1080' [patent_app_type] => new [patent_app_number] => 10/344503 [patent_app_country] => US [patent_app_date] => 2003-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15134 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20040005661.pdf [firstpage_image] =>[orig_patent_app_number] => 10344503 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/344503
Potential growth factors from the human tumour cell line ht 1080 Jul 7, 2003 Abandoned
Array ( [id] => 7247293 [patent_doc_number] => 20050272093 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-08 [patent_title] => 'Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof' [patent_app_type] => utility [patent_app_number] => 10/613744 [patent_app_country] => US [patent_app_date] => 2003-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 36474 [patent_no_of_claims] => 68 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0272/20050272093.pdf [firstpage_image] =>[orig_patent_app_number] => 10613744 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/613744
Assays for screening compounds which interact with cation channel proteins, mutant prokaryotic cation channel proteins, and uses thereof Jul 2, 2003 Abandoned
Array ( [id] => 7395538 [patent_doc_number] => 20040018199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-01-29 [patent_title] => 'Compositions and methods of use for an ephrin receptor' [patent_app_type] => new [patent_app_number] => 10/449569 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 47202 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 171 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20040018199.pdf [firstpage_image] =>[orig_patent_app_number] => 10449569 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/449569
Compositions and methods of use for an ephrin receptor May 28, 2003 Abandoned
Array ( [id] => 6796867 [patent_doc_number] => 20030175741 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Schizophrenia related gene' [patent_app_type] => new [patent_app_number] => 10/240154 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 10234 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 33 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20030175741.pdf [firstpage_image] =>[orig_patent_app_number] => 10240154 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/240154
Schizophrenia related gene Apr 28, 2003 Abandoned
Array ( [id] => 7286943 [patent_doc_number] => 20040146945 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Olfactory neuron cultures and method of making and using the same' [patent_app_type] => new [patent_app_number] => 10/422005 [patent_app_country] => US [patent_app_date] => 2003-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6113 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146945.pdf [firstpage_image] =>[orig_patent_app_number] => 10422005 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/422005
Olfactory neuron cultures and method of making and using the same Apr 22, 2003 Abandoned
Array ( [id] => 6968872 [patent_doc_number] => 20050235365 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Helicokinin-receptor from insects' [patent_app_type] => utility [patent_app_number] => 10/511221 [patent_app_country] => US [patent_app_date] => 2003-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6984 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20050235365.pdf [firstpage_image] =>[orig_patent_app_number] => 10511221 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511221
Helicokinin-receptor from insects Apr 3, 2003 Abandoned
Array ( [id] => 6953074 [patent_doc_number] => 20050228169 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-13 [patent_title] => 'Polypeptide binding to human syntaxin 1a' [patent_app_type] => utility [patent_app_number] => 10/508190 [patent_app_country] => US [patent_app_date] => 2003-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 12732 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0228/20050228169.pdf [firstpage_image] =>[orig_patent_app_number] => 10508190 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/508190
Polypeptide binding to human syntaxin 1a Mar 18, 2003 Abandoned
Array ( [id] => 7394054 [patent_doc_number] => 20040038343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-26 [patent_title] => 'G-protein coupled receptors' [patent_app_type] => new [patent_app_number] => 10/363481 [patent_app_country] => US [patent_app_date] => 2003-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40038 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0038/20040038343.pdf [firstpage_image] =>[orig_patent_app_number] => 10363481 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/363481
G-protein coupled receptors Feb 26, 2003 Abandoned
Array ( [id] => 7464779 [patent_doc_number] => 20040166535 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-26 [patent_title] => 'Method fo assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters' [patent_app_type] => new [patent_app_number] => 10/374288 [patent_app_country] => US [patent_app_date] => 2003-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4600 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20040166535.pdf [firstpage_image] =>[orig_patent_app_number] => 10374288 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/374288
Method of assessing antidepressant drug therapy via transport inhibition of monoamine neurotransmitters Feb 24, 2003 Issued
Array ( [id] => 7467490 [patent_doc_number] => 20040053826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-18 [patent_title] => 'Uses of polypeptides' [patent_app_type] => new [patent_app_number] => 10/344381 [patent_app_country] => US [patent_app_date] => 2003-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 80355 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20040053826.pdf [firstpage_image] =>[orig_patent_app_number] => 10344381 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/344381
Uses of polypeptides Feb 5, 2003 Abandoned
Array ( [id] => 6769847 [patent_doc_number] => 20030215787 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-20 [patent_title] => 'Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states' [patent_app_type] => new [patent_app_number] => 10/349670 [patent_app_country] => US [patent_app_date] => 2003-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8573 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20030215787.pdf [firstpage_image] =>[orig_patent_app_number] => 10349670 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/349670
Modulators of the CLC-7 chloride channel and methods for their identification and use in the treatment and prevention of osteoporosis and related disease states Jan 22, 2003 Abandoned
10/332721 C1Q-related factor, homologous polypeptides and therapeutic uses thereof Jan 8, 2003 Abandoned
Array ( [id] => 6822079 [patent_doc_number] => 20030220240 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-27 [patent_title] => 'Vesicle trafficking proteins' [patent_app_type] => new [patent_app_number] => 10/168659 [patent_app_country] => US [patent_app_date] => 2002-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38489 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0220/20030220240.pdf [firstpage_image] =>[orig_patent_app_number] => 10168659 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/168659
Vesicle trafficking proteins Dec 26, 2002 Abandoned
Menu